Henry Meds vs Priority Meds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Henry Meds
Best for mainstream telehealth GLP-1 accessStarting at $249/mo
Priority Meds
Best for pending product verificationStarting at $113/mo
Side-by-Side Comparison
| Feature | Henry Meds | Priority Meds |
|---|---|---|
| Overall Score | ✓7.2/10 | 7.1/10 |
| Starting Price | $249/mo | ✓$113/mo |
| Editorial Rating | 3.6 ★ /5 | 3.6 ★ /5 |
| Features | 4 features | 4 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Henry Meds
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Priority Meds
Pros
- ✓Flat-dose pricing (no dose-escalation increases) per competitor sources
- ✓B-vitamin co-compounding (sema+B12, tirz+B6) is a differentiator in the segment
- ✓Clearwater FL based US operation
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
Our Verdict
Henry Meds edges out Priority Meds with a higher overall score of 7.2/10 and is particularly strong for mainstream telehealth GLP-1 access. Priority Meds remains a solid alternative, especially if you're looking for pending product verification.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.